{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20140312",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20160908",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "45267",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022548s002lbl.pdf",
              "date": "20160908",
              "type": "Label"
            },
            {
              "id": "45279",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/022548Orig1s002ltr.pdf",
              "date": "20160912",
              "type": "Letter"
            },
            {
              "id": "73161",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/022548Orig1s002.pdf",
              "date": "20230117",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20100518",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "38834",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022548s000lbl.pdf",
              "date": "20100528",
              "type": "Label"
            },
            {
              "id": "42556",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022548s000_zymaxid_toc.html",
              "date": "20101208",
              "type": "Review"
            },
            {
              "id": "53282",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/022548_Gatifloxacin_Clinical_PREA.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "53283",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/022548_Gatifloxacin_Clinpharm_PREA.pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "53284",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/22548_Gatifloxacin_Statistical_PREA.pdf",
              "date": "19000101",
              "type": "Pediatric Statistical Review"
            },
            {
              "id": "7525",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022548s000ltr.pdf",
              "date": "20100521",
              "type": "Letter"
            },
            {
              "id": "24336",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022548s000_zymaxid_toc.html",
              "date": "20110217",
              "type": "Summary Review"
            }
          ]
        }
      ],
      "application_number": "NDA022548",
      "sponsor_name": "ABBVIE",
      "openfda": {
        "application_number": [
          "NDA022548"
        ],
        "brand_name": [
          "ZYMAXID"
        ],
        "generic_name": [
          "GATIFLOXACIN"
        ],
        "manufacturer_name": [
          "Allergan, Inc."
        ],
        "product_ndc": [
          "0023-3615"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "OPHTHALMIC"
        ],
        "substance_name": [
          "GATIFLOXACIN"
        ],
        "rxcui": [
          "992395",
          "992399"
        ],
        "spl_id": [
          "8ecbdc67-bc68-4437-b99d-9924e25dfe67"
        ],
        "spl_set_id": [
          "1160b16c-929a-4e85-9c0b-1d8c96a7678b"
        ],
        "package_ndc": [
          "0023-3615-01",
          "0023-3615-25"
        ],
        "unii": [
          "L4618BD7KJ"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "ZYMAXID",
          "active_ingredients": [
            {
              "name": "GATIFLOXACIN",
              "strength": "0.5%"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "SOLUTION/DROPS",
          "route": "OPHTHALMIC",
          "marketing_status": "Prescription",
          "te_code": "AT"
        }
      ]
    }
  ]
}